• Ovarian - Epithelial
• Ovarian - Non-Epithelial
  
• Cervical
• Endometrial
  
• Gestational Trophoblastic Neoplasia (GTN)
• Other

Ovarian Cancer - Epithelial

Chemotherapy: Platinum-containing regimens

GOCABR

Alternative Treatment of Gynecological Malignancies Using CARBOplatin and PACLitaxel NAB (ABRAXANE)

• GOCABR Protocol 
  
• GOCABR Preprinted Order 
  
• GOCABR Patient Handout
  

GOCABRBEV

Alternative Treatment of Gynecological Malignancies Using Bevacizumab, CARBOplatin and PACLitaxel NAB (ABRAXANE)

• GOCABRBEV Protocol 
  
• GOCABRBEV Preprinted Order 
  
• GOCABRBEV Patient Handout
  

GOCISP

Alternative Treatment of Gynecological Malignancies Using CISplatin and PACLitaxel

• GOCISP Protocol 
  
• GOCISP Preprinted Order 
  

GOCISPBEV

Alternative Treatment of Gynecological Malignancies using Bevacizumab, CISplatin and PACLitaxel

• GOCISPBEV Protocol 
  
• GOCISPBEV Preprinted Order 
  

GOOVCAD

Primary Treatment with Visible or No Visible Residual Tumour (Moderate, High, or Extreme Risk) or Treatment at Relapse of Invasive Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer, using CARBOplatin and DOCEtaxel

• GOOVCAD Protocol 
  
• GOOVCAD Preprinted Order 
  

GOOVCAG

Treatment of Advanced Ovarian Cancer in Patients Who Have Progressed or Recurred Following First-line Platinum-based Treatment Using CARBOplatin and Gemcitabine

• GOOVCAG Protocol
  
• GOOVCAG Preprinted Order 
  

GOOVCARB

First or Second Line Therapy for Invasive Epithelial Ovarian Cancer Using Single-Agent CARBOplatin

• GOOVCARB Protocol 
  
• GOOVCARB Preprinted Order
  

GOOVCATB

Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer with High Risk Of Relapse Using Bevacizumab, CARBOplatin and PACLitaxel

• GOOVCATB Protocol 
  
• GOOVCATB Preprinted Order Induction
  
• GOOVCATB Preprinted Order  Maintenance
  

GOOVCATM

Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer, with No Visible Residual Tumour (Moderate-High Risk) Using CARBOplatin and PACLitaxel

• GOOVCATM Protocol 
• GOOVCATM Preprinted Order 
• GOOVCATM Patient Handout 

GOOVCATR

Second Line Treatment of Invasive Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Relapsing after Primary Treatment Using PACLitaxel and CARBOplatin

• GOOVCATR Protocol 
  
• GOOVCATR Preprinted Order 
  
• GOOVCATR Patient Handout 
  

GOOVCATX

Primary Treatment of Visible Residual (Extreme Risk) Invasive Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Using CARBOplatin and PACLitaxel

• GOOVCATX Protocol 
• GOOVCATX Preprinted Order 
• GOOVCATX Patient Handout 

GOOVCIS

Therapy for Invasive Epithelial Ovarian Cancer using CISplatin

• GOOVCIS Protocol 
• GOOVCIS Preprinted Order 
• GOOVCIS Patient Handout 
  

GOOVDDCAT

Treatment Of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using CARBOplatin and Weekly PACLitaxel

• GOOVDDCAT Protocol 
• GOOVDDCAT Preprinted Order 
• GOOVDDCAT Patient Handout 

GOOVFPLDC

First Line Treatment of Epithelial Ovarian Cancer Using DOXOrubicin Pegylated Liposomal (CAELYX) and CARBOplatin

• GOOVFPLDC Protocol 
• GOOVFPLDC Preprinted Order 
  

GOOVIPPC

Primary Treatment of Stage III less than or equal to 1 cm Visible Residual Invasive Epithelial Ovarian Cancer or Stage 1 Grade 3 or Stage II Grade 3 Papillary Serous Ovarian Cancer Using Intravenous and Intraperitoneal PACLitaxel and Intraperitoneal CARBOplatin

• GOOVIPPC Protocol 
• GOOVIPPC Preprinted Order 
• GOOVIPPC Patient Handout
  

GOOVPLDC

Treatment of Epithelial Ovarian Cancer Relapsing after Primary Treatment Using DOXOrubicin Pegylated Liposomal (CAELYX) and CARBOplatin

• GOOVPLDC Protocol
  
• GOOVPLDC Preprinted Order
• GOOVPLDC Patient Handout
  

Chemotherapy: Non-platinum-containing regimens

GOOVBEVG

Treatment of Platinum Resistant or Refractory Epithelial Ovarian Cancer with Bevacizumab and Gemcitabine

• GOOVBEVG Protocol
  
• GOOVBEVG Preprinted Order
  

GOOVBEVLD

Treatment of Resistant or Refractory Epithelial Ovarian Cancer with Bevacizumab and DOXOrubicin Pegylated Liposomal

• GOOVBEVLD Protocol
  
• GOOVBEVLD Preprinted Order
  

GOOVBEVP

Treatment of Platinum Resistant or Refractory Epithelial Ovarian Cancer with Bevacizumab and PACLitaxel

• GOOVBEVP Protocol
  
• GOOVBEVP Preprinted Order
  

GOOVBEVV

Treatment of Platinum Resistant or Refractory Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine

• GOOVBEVV Protocol
  
• GOOVBEVV Preprinted Order
  

GOOVCYCPO

Palliative Therapy for Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Metronomic Low-Dose Oral Cyclophosphamide 

• GOOVCYCPO Protocol
• GOOVCYCPO Preprinted Order

GOOVDOC

Treatment of Progressive, Platinum-Refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma or Fallopian Tube Carcinoma Using DOCEtaxel

• GOOVDOC Protocol
• GOOVDOC Preprinted Order 

GOOVETO

Treatment of Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Etoposide

• GOOVETO Protocol
• GOOVETO Preprinted Order 
  

GOOVFNIRM

Maintenance Treatment of Newly Diagnosed Platinum Responsive Epithelial Ovarian Cancer using Niraparib

• GOOVFNIRM Protocol
  
• GOOVFNIRM Preprinted Order 
  

GOOVFOLAM

Maintenance Treatment of Newly Diagnosed BRCA-Mutated Platinum Responsive Epithelial Ovarian Cancer using Olaparib

• GOOVFOLAM Protocol
  
• GOOVFOLAM Preprinted Order 
  

GOOVGEM

Treatment of Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Gemcitabine

• GOOVGEM Protocol
  
• GOOVGEM Preprinted Order 

GOOVLDOX

Treatment of Epithelial Ovarian Cancer Relapsing after Primary Treatment Using DOXOrubicin Pegylated Liposomal (CAELYX)

• GOOVLDOX Protocol
• GOOVLDOX Preprinted Order
• GOOVLDOX Patient Handout

GOOVNIRAM

Maintenance Treatment of Relapsed Platinum Sensitive and Responsive Epithelial Ovarian Cancer using Niraparib

• GOOVNIRAM Protocol
  
• GOOVNIRAM Preprinted Order 
  

GOOVOLAPM

Maintenance Treatment of Relapsed, BRCA-mutated, Platinum Sensitive and Responsive Epithelial Ovarian Cancer Using Olaparib

• GOOVOLAPM Protocol
  
• GOOVOLAPM Preprinted Order 
  

GOOVTAX3

Treatment of Progressive, Platinum-refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma or Fallopian Tube Carcinoma Using PACLitaxel

• GOOVTAX3 Protocol
• GOOVTAX3 Preprinted Order 
  

GOOVTOP

Treatment of Relapsed/Progressive Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Using Topotecan

• GOOVTOP Protocol
  
• GOOVTOP Preprinted Order
  

GOOVVIN

Palliative Chemotherapy for Re-treatment of Ovarian, Tubal, and Peritoneal Cancer Using Vinorelbine

• GOOVVIN Protocol
• GOOVVIN Preprinted Order 

Hormonal therapy

GOOVAI

Therapy for Advanced Ovarian Cancer Using an Aromatase Inhibitor

• GOOVAI Protocol
  
• GOOVAI Preprinted Order 

GOOVTAM

Therapy for Advanced Ovarian Cancer Using Tamoxifen

• GOOVTAM Protocol 
• GOOVTAM Preprinted Order 

Ovarian Cancer - Non-Epithelial

GOBEP

Therapy of Non-Dysgerminomatous Ovarian Germ Cell Cancer Using Bleomycin, Etoposide and CISplatin

• GOBEP Protocol 
• GOBEP Preprinted Order 
• GOBEP Patient Handout 
  

GOEP

Therapy of Non-Dysgerminomatous Ovarian Germ Cell Cancer Using Etoposide and CISplatin

• GOEP Protocol 
• GOEP Preprinted Order
  

Cervical

GOCABR

GOCABRBEV

GOCISP

(SEE UNDER OVARIAN - EPITHELIAL SECTION)

GOCXAJCAT (deleted 01 Nov 2021)

GOCXBP

Maintenance Therapy of Squamous, Adenocarcinoma, or Adenosquamous Cancer of the Cervix with Pembrolizumab with or without Bevacizumab

• GOCXBP Protocol 
  
• GOCXBP Preprinted Order 
• GOCXBP Patient Handout
  

GOCXBP6

Maintenance Therapy of Squamous, Adenocarcinoma, or Adenosquamous Cancer of the Cervix with 6-Weekly Pembrolizumab with or without Bevacizumab

• GOCXBP6 Protocol 
• GOCXBP6 Preprinted Order 
  
• GOCXBP6 Patient Handout
  

GOCXCAD

Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with CARBOplatin and DOCEtaxel in Ambulatory Care Settings

• GOCXCAD Protocol
  
• GOCXCAD Preprinted Order 
  

GOCXCAT

Primary Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with CARBOplatin and PACLitaxel in Ambulatory Care Settings

• GOCXCAT Protocol 
• GOCXCAT Preprinted Order 

GOCXCATB

Primary Treatment of Metastatic or Recurrent Cancer of the Cervix with Bevacizumab, CARBOplatin and PACLitaxel

• GOCXCATB Protocol 
• GOCXCATB Preprinted Order 
• GOCXCATB Patient Handout
  

UGOCXCATBP

Primary Treatment of Squamous, Adenocarcinoma, or Adenosquamous Cancer of the Cervix with Bevacizumab, CARBOplatin, PACLitaxel and Pembrolizumab

• UGOCXCATBP Protocol 
• UGOCXCATBP Preprinted Order 
• UGOCXCATBP Patient Handout
  

UGOCXCATP

Primary Treatment of Squamous, Adenocarcinoma, or Adenosquamous Cancer of the Cervix with CARBOplatin, PACLitaxel, and Pembrolizumab

• UGOCXCATP Protocol 
• UGOCXCATP Preprinted Order 
• UGOCXCATP Patient Handout
  

GOCXCPNBP

Alternative Treatment of Squamous, Adenocarcinoma, or Adenosquamous Cancer of the Cervix with Bevacizumab, CARBOplatin, PACLitaxel NAB (ABRAXANE) and Pembrolizumab

• GOCXCPNBP Protocol 
  
• GOCXCPNBP Preprinted Order 
  

GOCXCPNP

Alternative Treatment of Squamous, Adenocarcinoma, or Adenosquamous Cancer of the Cervix with CARBOplatin, PACLitaxel NAB (ABRAXANE), and Pembrolizumab

• GOCXCPNP Protocol 
  
• GOCXCPNP Preprinted Order 
  

GOCXCRT

Treatment of High Risk Squamous Carcinoma, Adenocarcinoma, or Adenosquamous Carcinoma of the Cervix with Concurrent CISplatin and Radiation

• GOCXCRT Protocol
  
• GOCXCRT Preprinted Order 
  
• GOCXCRT Patient Handout
  

Endometrial

Chemotherapy

GOCABR

GOCABRBEV

GOCISP

GOCISPBEV

(SEE UNDER OVARIAN - EPITHELIAL SECTION)

GOENDAJCAT

Neoadjuvant or Adjuvant Treatment of Endometrial Cancer using CARBOplatin and PACLitaxel

• GOENDAJCAT Protocol 
  
• GOENDAJCAT Preprinted Order 
  
• GOENDAJCAT Patient Handout
  

GOENDAVCAT

Treatment of Advanced or Recurrent Endometrial Cancer using CARBOplatin and PACLitaxel

• GOENDAVCAT Protocol 
  
• GOENDAVCAT Preprinted Order 
  
• GOENDAVCAT Patient Handout
  

UGOENDAVP

Treatment of Microsatellite Instability-High or Mismatch Repair Deficient Endometrial Cancer using Pembrolizumab

• UGOENDAVP Protocol 
  
• UGOENDAVP Preprinted Order 
  

UGOENDAVP6

Treatment of Microsatellite Instability-High or Mismatch Repair Deficient Endometrial Cancer using 6-Weekly Pembrolizumab

• UGOENDAVP6 Protocol 
• UGOENDAVP6 Preprinted Order 
  

GOENDAVPL

Treatment of Endometrial Cancer Without Microsatellite Instability-High or Mismatch Repair Deficiency using Pembrolizumab and Lenvatinib

• GOENDAVPL Protocol 
  
• GOENDAVPL Preprinted Order 
  

GOENDAVPL6

Treatment of Endometrial Cancer Without Microsatellite Instability-High or Mismatch Repair Deficiency using 6-weekly Pembrolizumab and Lenvatinib

• GOENDAVPL6 Protocol 
  
• GOENDAVPL6 Preprinted Order 
  

GOENDCAD

Treatment of Primary Advanced or Recurrent Endometrial Cancer using CARBOplatin and DOCEtaxel

• GOENDCAD Protocol 
• GOENDCAD Preprinted Order 
  

GOENDCAT

Treatment of Primary Advanced or Recurrent Endometrial Cancer using CARBOplatin and PACLitaxel

• GOENDCAT Protocol 
  
• GOENDCAT Preprinted Order 
  
• GOENDCAT Patient Handout 

GOENDD

DOXOrubicin for Use in Patients with Advanced Endometrial Cancer

• GOENDD Protocol 
  
• GOENDD Preprinted Order 

Hormonal therapy

GOENDAI

Advanced Therapy for Endometrial Cancer using an Aromatase Inhibitor

• GOENDAI Protocol
  
• GOENDAI Preprinted Order 

GOENDH

Non-Aromatase Inhibitor Hormonal Treatment of Endometrial Cancer

• GOENDH Protocol
  
• GOENDH Preprinted Order 

Gestational Trophoblastic Neoplasia (GTN)

GOTDEMACO

Therapy for High Risk Gestational Trophoblastic Neoplasia (GTN) Using Etoposide, Methotrexate, Leucovorin (Folinic Acid), DACTINomycin, Cyclophosphamide and vinCRIStine

• GOTDEMACO Protocol
• GOTDEMACO Preprinted Order
• GOTDEMACO Patient Handout

GOTDLRA

Therapy for Low Risk Gestational Trophoblastic Cancer using DACTINomycin

• GOTDLRA Protocol
• GOTDLRA Preprinted Order

GOTDLRM

Therapy for Low Risk Gestational Trophoblastic Cancer using Methotrexate

• GOTDLRM Protocol
  
• GOTDLRM Preprinted Order 
  
• GOTDLRM Patient Handout
  

GOTDMR

Therapy for Moderate Risk Gestational Trophoblastic Cancer using DACTINomycin and Methotrexate

• GOTDMR Protocol 
  

Other

GOSAD

DOXOrubicin for Use in Patients with Advanced Uterine Sarcoma

• GOSAD Protocol
• GOSAD Preprinted Order

GOSADG

Treatment of Uterine Sarcoma Cancer using DOCEtaxel and Gemcitabine

• GOSADG Protocol
• GOSADG Preprinted Order